Functional analysis of the cathepsin-like cysteine protease genes in adult Brugia malayi using RNA interference

PLoS Neglected Tropical Diseases

Volumn 3, Issue 2, 2009, Pages

  Ford, Louise ^a,c   Zhang, Jun ^a   Liu, Jing ^a   Hashmi, Sarwar ^a   Fuhrman, Juliet A ^b   Oksov, Yelena ^a   Lustigman, Sara ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE; DOUBLE STRANDED RNA; MICROORGANISM PROTEIN; PROTEIN CPL; PROTEIN CPL 1; PROTEIN CPL 5; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BRUGIA MALAYI; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; GENE FUNCTION; GENE TARGETING; GENETIC CONSERVATION; MICROFILARIA; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PROGENY; RNA INTERFERENCE; ANIMAL; ENZYMOLOGY; FEMALE; GENE; GENETICS; METABOLISM;

ANIMALS; BRUGIA MALAYI; CATHEPSINS; CYSTEINE PROTEASES; FEMALE; GENES, HELMINTH; RNA INTERFERENCE; RNA, DOUBLE-STRANDED;

EID: 65549112118     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000377     Document Type: Article

References (85)

1. WHO (2006) Neglected tropical diseases. Preventive chemotherapy and transmission control.
2. Molyneux DH, Bradley M, Hoerauf A, Kyelem D, Taylor MJ (2003) Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol 19: 516-522.
3. Molyneux DH, Zagaria N (2002) Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 Suppl 2: S15-40.
4. Dadzie Y, Neira M, Hopkins D (2003) Final report of the Conference on the eradicability of Onchocerciasis. Filaria J 2: 2.
5. Liu LX, Weller PF (1996) Antiparasitic drugs. N Engl J Med 334: 1178-1184.
6. Richard-Lenoble D, Chandenier J, Gaxotte P (2003) Ivermectin and filariasis. Fundam Clin Pharmacol 17: 199-203.
7. Prichard RK (2007) Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs. Expert Opin Drug Discov 2: S41-S52.
8. Townson S, Ramirez B, Fakorede F, Mouries M, Nwaka S (2007) Challenges in drug discovery for novel antifilarials. Expert Opin Drug Discov 2: S63-S73.
9. Coles GC, Jackson F, Pomroy WE, Prichard RK, von Samson-Himmelstjerna G, et al. (2006) The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol 136: 167-185.
10. Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, et al. (2004) Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 359-370.
11. Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, et al. (2004) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 231-249.
12. Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021-2029.
13. Lustigman S, McCarter JP (2007) Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis. PLoS Negl Trop Dis 1: e76. doi:10.1371/journal.pntd.0000076.
14. Bourguinat C, Pion SD, Kamgno J, Gardon J, Duke BO, et al. (2007) Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment. PLoS Negl Trop Dis 1: e72. doi: 10.1371/journal.pntd.0000072.
15. Hotez PJ (2007) Control of onchocerciasis-the next generation. Lancet 369: 1979-1980.
16. Johnston KL, Taylor MJ (2007) Wolbachia in filarial parasites: targets for filarial infection and disease control. Curr Infect Dis Rep 9: 55-59.
17. Hoerauf A (2008) Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis 21: 673-681.
18. Hudson A, Nwaka S (2007) The Concept Paper on the Helminth Drug Initiative. Onchocerciasis/lymphatic filariasis and schistosomiasis: opportunities and challenges for the discovery of new drugs/diagnostics. Expert Opin Drug Discov 2: S3-S7.
19. Berriman M, Lustigman S, McCarter JP (2007) Genomics and Emerging Drug Discovery Technologies. Expert Opin Drug Discov 2: S83-S89.
20. Grant WN, Behm CA (2007) Target identification and validation for anthelmintic discovery. Expert Opin Drug Discov 2: S91-S98.
21. WHO/TDR JPS (2007) Summary report from the Helminth Drug Initiative Consultation Meetings: Informal consultation of experts to advice TDR on the proposed initiative. Expert Opin Drug Discov 2: S99-S103.
22. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
23. Maeda I, Kohara Y, Yamamoto M, Sugimoto A (2001) Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr Biol 11: 171-176.
24. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231-237.
25. Sonnichsen B, Koski LB, Walsh A, Marschall P, Neumann B, et al. (2005) Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 434: 462-469.
26. Behm CA, Bendig MM, McCarter JP, Sluder AE (2005) RNAi-based discovery and validation of new drug targets in filarial nematodes. Trends Parasitol 21: 97-100.
27. Hashmi S, Tawe W, Lustigman S (2001) Caenorhabditis elegans and the study of gene function in parasites. Trends Parasitol 17: 387-393.
28. Foster JM, Zhang Y, Kumar S, Carlow CK (2005) Mining nematode genome data for novel drug targets. Trends Parasitol 21: 101-104.
29. Kumar S, Chaudhary K, Foster JM, Novelli JF, Zhang Y, et al. (2007) Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets. PLoS ONE 2: e1189. doi:10.1371/journal.pone.0001189.
30. Geldhof P, Visser A, Clark D, Saunders G, Britton C, et al. (2007) RNA interference in parasitic helminths: current situation, potential pitfalls and future prospects. Parasitology 134: 609-619.
31. Lustigman S, Ford L, Crawford MJ (2008) RNA Interference: From functional genomics to validation of drug targets in helminths. In: Lyland RT, Browning IB eds. RNA Interference Research Progress Nova Science Publishers, Inc. pp 135-162.
32. Ford L, Guiliano DB, Oksov Y, Debnath AK, Liu J, et al. (2005) Characterization of a Novel Filarial Serine Protease Inhibitor, Ov-SPI-1, from Onchocerca volvulus, with Potential Multifunctional Roles during Development of the Parasite. J Biol Chem 280: 40845-40856.
33. Lustigman S, Zhang J, Lui J, Oksov Y, Hashmi S (2004) RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting. Mol Biochem Parasitol 138: 165-170.
34. Aboobaker AA, Blaxter ML (2003) Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi. Mol Biochem Parasitol 129: 41-51.
35. Pfarr K, Heider U, Hoerauf A (2006) RNAi mediated silencing of actin expression in adult Litomosoides sigmodontis is specific, persistent and results in a phenotype. Int J Parasitol 36: 661-669.
36. Tachu B, Pillai S, Lucius R, Pogonka T (2008) Essential role of chitinase in the development of the filarial nematode Acanthocheilonema viteae. Infect Immun 76: 221-228.
37. Knox DP, Geldhof P, Visser A, Britton C (2007) RNA interference in parasitic nematodes of animals: a reality check? Trends Parasitol 23: 105-107.
38. Poole CB, Jin J, McReynolds LA (2007) Subtilisin-like proteases in nematodes. Mol Biochem Parasitol 155: 1-8.
39. Guiliano DB, Hong X, McKerrow JH, Blaxter ML, Oksov Y, et al. (2004) A gene family of cathepsin L-like proteases of filarial nematodes are associated with larval molting and cuticle and eggshell remodeling. Mol Biochem Parasitol 136: 227-242.
40. Hashmi S, Britton C, Liu J, Guiliano DB, Oksov Y, et al. (2002) Cathepsin L is essential for embryogenesis and development of Caenorhabditis elegans. J Biol Chem 277: 3477-3486.
41. Britton C, Murray L (2004) Cathepsin L protease (CPL-1) is essential for yolk processing during embryogenesis in Caenorhabditis elegans. J Cell Sci 117: 5133-5143.
42. Wu L, Belasco JG (2008) Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell 29: 1-7.
43. Morris KV (2008) RNA-mediated transcriptional gene silencing in human cells. Curr Top Microbiol Immunol 320: 211-224.
44. Hashmi S, Zhang J, Oksov Y, Lustigman S (2004) The Caenorhabditis elegans cathepsin Z-like cysteine protease, Ce-CPZ-1, has a multifunctional role during the worms' development. J Biol Chem 279: 6035-6045.
45. Comley JC, Rees MJ, Turner CH, Jenkins DC (1989) Colorimetric quantitation of filarial viability. Int J Parasitol 19: 77-83.
46. Williamson AL, Lecchi P, Turk BE, Choe Y, Hotez PJ, et al. (2004) A multienzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem 279: 35950-35957.
47. Williamson AL, Brindley PJ, Knox DP, Hotez PJ, Loukas A (2003) Digestive proteases of blood-feeding nematodes. Trends Parasitol 19: 417-423.
48. Delcroix M, Sajid M, Caffrey CR, Lim KC, Dvorak J, et al. (2006) A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite. J Biol Chem 281: 39316-39329.
49. Lustigman S, McKerrow JH, Shah K, Lui J, Huima T, et al. (1996) Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. J Biol Chem 271: 30181-30189.
50. Dalton JP, Neill SO, Stack C, Collins P, Walshe A, et al. (2003) Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol 33: 1173-1181.
51. Tort JF, Brindley PJ, Knox D, Wolfe KH, Dalton JP (1999) Proteinases and associated genes of parasitic helminths. Adv Parasitol 43: 161-266.
52. Britton C, Murray L (2002) A cathepsin L protease essential for Caenorhabditis elegans embryogenesis is functionally conserved in parasitic nematodes. Mol Biochem Parasitol 122: 21-33.
53. Medina M, Leon P, Vallejo CG (1988) Drosophila cathepsin B-like proteinase: a suggested role in yolk degradation. Arch Biochem Biophys 263: 355-363.
54. Cho WL, Tsao SM, Hays AR, Walter R, Chen JS, et al. (1999) Mosquito cathepsin B-like protease involved in embryonic degradation of vitellin is produced as a latent extraovarian precursor. J Biol Chem 274: 13311-13321.
55. Liu X, McCarron RC, Nordin JH (1996) A cysteine protease that processes insect vitellin. Purification and partial characterization of the enzyme and the proenzyme. J Biol Chem 271: 33344-33351.
56. Manoury B, Gregory WF, Maizels RM, Watts C (2001) Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 11: 447-451.
57. Turk V, Stoka V, Turk D (2008) Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 13: 5406-5420.
58. Henskens YM, Veerman EC, Nieuw Amerongen AV (1996) Cystatins in health and disease. Biol Chem Hoppe Seyler 377: 71-86.
59. Hashmi S, Zhang J, Oksov Y, Ji Q, Lustigman S (2006) The Caenorhabditis elegans CPI-2a cystatin-like inhibitor has an essential regulatory role during oogenesis and fertilization. J Biol Chem 281: 28415-28429.
60. Doyle PS, Zhou YM, Engel JC, McKerrow JH (2007) A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection. Antimicrob Agents Chemother 51: 3932-3939.
61. Barr SC, Warner KL, Kornreic BG, Piscitelli J, Wolfe A, et al. (2005) A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. Antimicrob Agents Chemother 49: 5160-5161.
62. Brak K, Doyle PS, McKerrow JH, Ellman JA (2008) Identification of a new class of nonpeptidic inhibitors of cruzain. J Am Chem Soc 130: 6404-6410.
63. Rosenthal PJ (2004) Cysteine proteases of malaria parasites. Int J Parasitol 34: 1489-1499.
64. Abdulla MH, Lim KC, Sajid M, McKerrow JH, Caffrey CR (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med 4: e14.
65. Alcala-Canto Y, Ibarra-Velarde F, Sumano-Lopez H, Gracia-Mora J, Alberti-Navarro A (2007) Effect of a cysteine protease inhibitor on Fasciola hepatica (liver fluke) fecundity, egg viability, parasite burden, and size in experimentally infected sheep. Parasitol Res 100: 461-465.
66. Choe Y, Leonetti F, Greenbaum DC, Lecaille F, Bogyo M, et al. (2006) Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J Biol Chem 281: 12824-12832.
67. Greenbaum DC, Mackey Z, Hansell E, Doyle P, Gut J, et al. (2004) Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J Med Chem 47: 3212-3219.
68. Greenbaum DC, Arnold WD, Lu F, Hayrapetian L, Baruch A, et al. (2002) Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem Biol 9: 1085-1094.
69. Issa Z, Grant WN, Stasiuk S, Shoemaker CB (2005) Development of methods for RNA interference in the sheep gastrointestinal parasite, Trichostrongylus colubriformis. Int J Parasitol 35: 935-940.
70. Krautz-Peterson G, Radwanska M, Ndegwa D, Shoemaker CB, Skelly PJ (2007) Optimizing gene suppression in schistosomes using RNA interference. Mol Biochem Parasitol 153: 194-202.
71. Osman A, Niles EG, Verjovski-Almeida S, LoVerde PT (2006) Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog 2: e54. doi:10.1371/ journal.ppat.0020054.
72. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, et al. (2007) Draft genome of the filarial nematode parasite Brugia malayi. Science 317: 1756-1760.
73. Britton C, Murray L (2006) Using Caenorhabditis elegans for functional analysis of genes of parasitic nematodes. Int J Parasitol 36: 651-659.
74. Svoboda P (2007) Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 9: 248-257.
75. Skelly PJ, Da'dara A, Harn DA (2003) Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int J Parasitol 33: 363-369.
76. Dinguirard N, Yoshino TP (2006) Potential role of a CD36-like class B scavenger receptor in the binding of modified low-density lipoprotein (acLDL) to the tegumental surface of Schistosoma mansoni sporocysts. Mol Biochem Parasitol 146: 219-230.
77. Uematsu S, Akira S (2008) Toll-Like receptors (TLRs) and their ligands. Handb Exp Pharmacol. pp 1-20.
78. Saumet A, Lecellier CH (2006) Anti-viral RNA silencing: do we look like plants? Retrovirology 3: 3.
79. Dunoyer P, Voinnet O (2005) The complex interplay between plant viruses and host RNA-silencing pathways. Curr Opin Plant Biol 8: 415-423.
80. Lu R, Maduro M, Li F, Li HW, Broitman-Maduro G, et al. (2005) Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans. Nature 436: 1040-1043.
81. Lin SL, Miller JD, Ying SY (2006) Intronic MicroRNA (miRNA). J Biomed Biotechnol 2006: 26818.
82. Lin SL, Kim H, Ying SY (2008) Intron-mediated RNA interference and microRNA (miRNA). Front Biosci 13: 2216-2230.
83. Visser A, Geldhof P, de Maere V, Knox DP, Vercruysse J, et al. (2006) Efficacy and specificity of RNA interference in larval life-stages of Ostertagia ostertagi. Parasitology 133: 777-783.
84. Geldhof P, Murray L, Couthier A, Gilleard JS, McLauchlan G, et al. (2006) Testing the efficacy of RNA interference in Haemonchus contortus. Int J Parasitol 36: 801-810.
85. Maine EM (2008) Studying gene function in Caenorhabditis elegans using RNA-mediated interference. Brief Funct Genomic Proteomic 7: 184-194.